Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
7 participants
INTERVENTIONAL
2011-02-28
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
NCT06116149
Weight Management in Obese Pregnant Underserved African American Women
NCT01768793
Weight Loss in Chronic Disease Patient Population
NCT01155050
TARGETing Healthy Weight Loss in the Context of Food Insecurity
NCT05601804
LIFT: Lifestyle Interventions For Two
NCT01616147
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. decrease body weight and
2. reduce the rate of metabolic abnormalities, 12 months after delivery
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
A group matched for age and BMI will be selected to serve as control subjects in this study.
Non-intervention group
A pedometer and written material on a healthy lifestyle.
Face-to-face group
Participants randomized to the face-to-face intervention will attend motivational meetings held once per week in Phase I and biweekly in Phase II. Behavioral sessions will be led by a trained interventionist and will take place at Pennington Biomedical Research Center.
Face to face
Motivational meetings held once per week; Behavioral sessions weill be led by a trained interventionist.
Telehealth Group
Participants randomized to the Telehealth intervention will receive behavioral counseling through Trestletree, phone system.
Telehelath Group
Participants will speak to Trestletree personnel once a week via phone.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non-intervention group
A pedometer and written material on a healthy lifestyle.
Face to face
Motivational meetings held once per week; Behavioral sessions weill be led by a trained interventionist.
Telehelath Group
Participants will speak to Trestletree personnel once a week via phone.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English-speaking
Exclusion Criteria
* History or clinical manifestation of any other significant metabolic, hematologic, pulmonary, cardiovascular, gastrointestinal, neurologic, immune, hepatic, renal, urologic disorders, or cancer
* Regular use of medications for weight control or psychosis
* History or clinical manifestation of any eating disorder
* Smoking
* Pregnancy or pregnancy planned during the coming year
* Unwilling or unable to adhere to the clinical evaluation schedule over the twelve -month study period
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
THE C.B. AND IRENE PENNINGTON FOUNDATION
UNKNOWN
Pennington Biomedical Research Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Leanne Redman
Principle Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leanne M. Redman, PhD
Role: PRINCIPAL_INVESTIGATOR
Pennington Biomedical Research Center
Karen Elkind-Hirsh, PhD
Role: STUDY_DIRECTOR
Womans' Research Hospital
Catherine Chamagne, PhD
Role: STUDY_CHAIR
Pennington Biomedical Research Center
Timothy S. Church, MD, MPH, PhD
Role: STUDY_CHAIR
Pennington Biomedical Research Center
Eric Ravussin, PhD
Role: STUDY_CHAIR
Pennington Biomedical Reserach Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PBRC 10041
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.